{"id":"NCT03422653","sponsor":"Cara Therapeutics, Inc.","briefTitle":"A Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus (KALM-1)","officialTitle":"A Multicenter, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety and Efficacy of Intravenous CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus, With a 52-Week Open Label Extension","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-02-20","primaryCompletion":"2019-04-06","completion":"2020-03-26","firstPosted":"2018-02-06","resultsPosted":"2022-04-26","lastUpdate":"2022-04-26"},"enrollment":378,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Uremic Pruritus"],"interventions":[{"type":"DRUG","name":"CR845 0.5 mcg/kg","otherNames":["CR845","Difelikefalin"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"CR845 0.5mcg/kg","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of intravenous (IV) CR845 at a dose of 0.5 mcg/kg administered after each dialysis session. The study includes a 12-week Double-blind Phase and a 52-week Open-label Extension Phase.","primaryOutcome":{"measure":"Reduction of Itch Intensity as Assessed by the Percentage of Patients Achieving an Improvement From Baseline â‰¥3 Points With Respect to the Weekly Mean of the Daily 24-hour Worst Itching Intensity Numerical Rating Scale (NRS) Score at Week 12","timeFrame":"Week 12","effectByArm":[{"arm":"CR845 0.5mcg/kg","deltaMin":51,"sd":null},{"arm":"Placebo","deltaMin":27.6,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":8},"locations":{"siteCount":57,"countries":["United States"]},"refs":{"pmids":["39037824","37968132","36039153","36016762","33283264","31702883"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":49,"n":189},"commonTop":["Diarrhoea","Nausea","Fall","Hypotension","Vomiting"]}}